Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06793813 · RECRUITING
Trial details
- NCT number
- NCT06793813
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2025-12-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.